{"id":145429,"date":"2025-02-24T11:42:36","date_gmt":"2025-02-24T06:12:36","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=145429"},"modified":"2025-02-24T11:42:39","modified_gmt":"2025-02-24T06:12:39","slug":"pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/","title":{"rendered":"Pharma stock jumps after company to acquire 100% stake in Senn Chemicals for \u20b9192 Cr"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2757791422\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of this pharmaceutical stock, specializing in Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages, came into focus on Monday after the Board approved the acquisition of a 100 percent equity stake in Switzerland-based Senn Chemicals AG for Rs 192.5 crore.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2425352287\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Stock Performance<\/strong><\/h2><p>With a market capitalization of Rs 12,509.04 crore, <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/GRANULES\" target=\"_blank\" rel=\"noreferrer noopener\">Granules India Ltd <\/a><\/strong>jumped 2 percent in Monday\u2019s trading session and made a high of Rs 519 per share compared to its previous closing price of Rs 509 per share. The stock retraced from its day\u2019s high and was trading at Rs 515.85 which is 1.3 percent higher than the previous closing price.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened<\/strong><\/h2><p>In a company filing, Granules India Ltd announced the signing of an agreement to acquire Senn Chemicals AG, a Swiss CDMO specializing in peptides. This acquisition, expected to close in the first half of 2025, marks Granules\u2019 entry into the peptides segment and also strengthens its presence in the European CDMO market.<\/p><p>Senn develops and manufactures peptides and peptide-based applications for global customers. The company\u2019s expertise in Liquid-Phase and Solid-Phase Peptide Synthesis, along with its cGMP-certified manufacturing facility, enhances Granules&#8217; capabilities in high-growth peptide-based therapeutics, including GLP-1 receptor agonists for anti-diabetic and anti-obesity treatments.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-2668110678\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Company Overview<\/strong><\/h2><p>Granules India Limited is a pharmaceutical company specializing in active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs), and finished dosages (FDs). It operates more than eight manufacturing facilities, with seven in India and one in the United States. The company caters to global markets, including the US, Canada, Latin America, Europe, Asia-Pacific, and India, through its subsidiaries.<\/p><figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/lh7-rt.googleusercontent.com\/docsz\/AD_4nXefYYCAH2tlhmC8XI6MzwI2pmBIGto4TfPfJuGt72IOSjHXlBpQGmYwXoESO93H-NyNyGNGjaUlTdo2mUvVS95pJ3UKsTiRlSumqHq0dEk-L3Tit5EsrY48cm6FIXLMlodJqqJI?key=YA3m9A98Sn_p62vyjHeeKicr\" alt=\"\"\/><\/figure><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financial Performance<\/strong><\/h2><p>In the latest quarter, Granules reported a 1.6 percent YoY decrease in its revenue from Rs 1,156 crore to Rs 1,138 crore. On a quarterly basis, there was an 18 percent increase from Rs 967 crore in Q2 FY25.&nbsp;<\/p><p>This was accompanied by a 6 percent YoY fall in net profits from Rs 126 crore to Rs 118 crore. On a quarterly basis, the company saw a 22 percent increase in profits from Rs 97 crore in Q2 FY25.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Industry Outlook<\/strong><\/h2><p>India&#8217;s pharmaceutical industry ranks third globally by production volume and 14th by value, with around 3,000 drug companies and 10,000 manufacturing units. Valued at $58 billion, the sector is projected to reach $120-130 billion by 2030 and $400-450 billion by 2047. This growth would be driven by rising lifestyle diseases, an aging population, and increased healthcare consumerization.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Shwetha Sairam<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses <\/strong><\/p><div class=\"trade-content-10\" id=\"trade-2530610429\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-1081934859\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of this pharmaceutical stock, specializing in Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages, came into focus on Monday after the Board approved the acquisition of a 100 percent equity stake in Switzerland-based Senn Chemicals AG for Rs 192.5 crore. Stock Performance With a market capitalization of Rs 12,509.04 crore, [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[4912,18466,12738,6616,948,936,2597],"class_list":["post-145429","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-granules-india","tag-granules-india-news","tag-granules-india-share-price","tag-pharma-stock","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps after company to acquire 100% stake in Senn Chemicals for \u20b9192 Cr - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of this pharmaceutical stock, specializing in Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages, came into focus on Monday after the Board approved the acquisition of a 100 percent equity stake in Switzerland-based Senn Chemicals AG for Rs 192.5 crore.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps after company to acquire 100% stake in Senn Chemicals for \u20b9192 Cr\" \/>\n<meta property=\"og:description\" content=\"The shares of this pharmaceutical stock, specializing in Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages, came into focus on Monday after the Board approved the acquisition of a 100 percent equity stake in Switzerland-based Senn Chemicals AG for Rs 192.5 crore.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-24T06:12:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-24T06:12:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/\",\"name\":\"Pharma stock jumps after company to acquire 100% stake in Senn Chemicals for \u20b9192 Cr - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2025-02-24T06:12:36+00:00\",\"dateModified\":\"2025-02-24T06:12:39+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of this pharmaceutical stock, specializing in Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages, came into focus on Monday after the Board approved the acquisition of a 100 percent equity stake in Switzerland-based Senn Chemicals AG for Rs 192.5 crore.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps after company to acquire 100% stake in Senn Chemicals for \u20b9192 Cr\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps after company to acquire 100% stake in Senn Chemicals for \u20b9192 Cr - Trade Brains Features","description":"The shares of this pharmaceutical stock, specializing in Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages, came into focus on Monday after the Board approved the acquisition of a 100 percent equity stake in Switzerland-based Senn Chemicals AG for Rs 192.5 crore.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps after company to acquire 100% stake in Senn Chemicals for \u20b9192 Cr","og_description":"The shares of this pharmaceutical stock, specializing in Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages, came into focus on Monday after the Board approved the acquisition of a 100 percent equity stake in Switzerland-based Senn Chemicals AG for Rs 192.5 crore.","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-02-24T06:12:36+00:00","article_modified_time":"2025-02-24T06:12:39+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/","name":"Pharma stock jumps after company to acquire 100% stake in Senn Chemicals for \u20b9192 Cr - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2025-02-24T06:12:36+00:00","dateModified":"2025-02-24T06:12:39+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of this pharmaceutical stock, specializing in Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages, came into focus on Monday after the Board approved the acquisition of a 100 percent equity stake in Switzerland-based Senn Chemicals AG for Rs 192.5 crore.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-company-to-acquire-100-stake-in-senn-chemicals-for-192-cr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps after company to acquire 100% stake in Senn Chemicals for \u20b9192 Cr"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/145429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=145429"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/145429\/revisions"}],"predecessor-version":[{"id":145430,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/145429\/revisions\/145430"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=145429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=145429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=145429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}